J. Exp. Med.
© The Rockefeller University Press
0022-1007/97/03/1043/12 $2.00
Volume 185, Number 6, March 17, 1997 1043-1054

Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of  T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing

By Kevin L. Legge,^* Booki Min,^* Nicholas T. Potter, and Habib Zaghouani^*

From the ^* Department of Microbiology, University of Tennessee, Knoxville, Tennessee 37996; and  The Developmental and Genetic Center, University of Tennessee Medical Center, Knoxville, Tennessee 37920

T cell receptor (TCR) antagonism is being considered for inactivation of aggressive T cells and reversal of T cell-mediated autoimmune diseases. TCR antagonist peptides silence aggressive T cells and reverse experimental allergic encephalomyelitis induced with free peptides. However, it is not clear whether free antagonist peptides could reverse natural disease where the antigen is presumably available for endocytic processing and peptides gain access to newly synthesized class II MHC molecules. Using an efficient endocytic presentation system, we demonstrate that a proteolipid protein (PLP) TCR antagonist peptide (PLP-LR) presented on an Ig molecule (IgPLP-LR) abrogates the activation of T cells stimulated with free encephalitogenic PLP peptide (PLP1), native PLP, or an Ig containing PLP1 peptide (Ig-PLP1). Free PLP-LR abolishes T cell activation when the stimulator is free PLP1 peptide, but has no measurable effect when the stimulator is the native PLP or Ig-PLP1. In vivo, Ig-PLP1 induces a T cell response to PLP1 peptide. However, when coadministered with Ig-PLP-LR, the response to PLP1 peptide is markedly reduced whereas the response to PLP-LR is normal. Free PLP-LR coadministered with Ig-PLP1 has no effect on the T cell response to PLP1. These findings indicate that endocytic presentation of an antagonist peptide by Ig outcompete both external and endocytic agonist peptides whereas free antagonist hinders external but not endocytic agonist peptide. Direct contact with antagonist ligand and/or trans-regulation by PLP-LR-specific T cells may be the operative mechanism for Ig-PLP-LR-mediated downregulation of PLP1-specific T cells in vivo. Efficient endocytic presentation of antagonist peptides, which is the fundamental event for either mechanism, may be critical for reversal of spontaneous T cell-mediated autoimmune diseases where incessant endocytic antigen processing could be responsible for T cell aggressivity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Lee, H.-H., Hoeman, C. M., Hardaway, J. C., Guloglu, F. B., Ellis, J. S., Jain, R., Divekar, R., Tartar, D. M., Haymaker, C. L., Zaghouani, H. (2008). Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. JEM 205: 2269-2280 [Abstract] [Full Text]  
• Wegmann, K. W., Wagner, C. R., Whitham, R. H., Hinrichs, D. J. (2008). Synthetic Peptide Dendrimers Block the Development and Expression of Experimental Allergic Encephalomyelitis. J. Immunol. 181: 3301-3309 [Abstract] [Full Text]  
• Yu, P., Haymaker, C. L., Divekar, R. D., Ellis, J. S., Hardaway, J., Jain, R., Tartar, D. M., Hoeman, C. M., Cascio, J. A., Ostermeier, A., Zaghouani, H. (2008). Fetal Exposure to High-Avidity TCR Ligand Enhances Expansion of Peripheral T Regulatory Cells. J. Immunol. 181: 73-80 [Abstract] [Full Text]  
• Bell, J. J., Divekar, R. D., Ellis, J. S., Cascio, J. A., Haymaker, C. L., Jain, R., Tartar, D. M., Hoeman, C. M., Hardaway, J. C., Zaghouani, H. (2008). In Trans T Cell Tolerance Diminishes Autoantibody Responses and Exacerbates Experimental Allergic Encephalomyelitis. J. Immunol. 180: 1508-1516 [Abstract] [Full Text]  
• Jain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H.-H., Yu, P., Ellis, J. S., Hoeman, C. M., Franklin, C. L., Zaghouani, H. (2008). Innocuous IFN{gamma} induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. JEM 205: 207-218 [Abstract] [Full Text]  
• Caprio-Young, J. C., Bell, J. J., Lee, H.-H., Ellis, J., Nast, D., Sayler, G., Min, B., Zaghouani, H. (2006). Neonatally Primed Lymph Node, but Not Splenic T Cells, Display a Gly-Gly Motif within the TCR {beta}-Chain Complementarity-Determining Region 3 That Controls Affinity and May Affect Lymphoid Organ Retention. J. Immunol. 176: 357-364 [Abstract] [Full Text]  
• Yu, P., Gregg, R. K., Bell, J. J., Ellis, J. S., Divekar, R., Lee, H.-H., Jain, R., Waldner, H., Hardaway, J. C., Collins, M., Kuchroo, V. K., Zaghouani, H. (2005). Specific T Regulatory Cells Display Broad Suppressive Functions against Experimental Allergic Encephalomyelitis upon Activation with Cognate Antigen. J. Immunol. 174: 6772-6780 [Abstract] [Full Text]  
• Gregg, R. K., Bell, J. J., Lee, H.-H., Jain, R., Schoenleber, S. J., Divekar, R., Zaghouani, H. (2005). IL-10 Diminishes CTLA-4 Expression on Islet-Resident T Cells and Sustains Their Activation Rather Than Tolerance. J. Immunol. 174: 662-670 [Abstract] [Full Text]  
• Bell, J. J., Min, B., Gregg, R. K., Lee, H.-H., Zaghouani, H. (2003). Break of Neonatal Th1 Tolerance and Exacerbation of Experimental Allergic Encephalomyelitis by Interference with B7 Costimulation. J. Immunol. 171: 1801-1808 [Abstract] [Full Text]  
• Zaliauskiene, L., Kang, S., Sparks, K., Zinn, K. R., Schwiebert, L. M., Weaver, C. T., Collawn, J. F. (2002). Enhancement of MHC Class II-Restricted Responses by Receptor-Mediated Uptake of Peptide Antigens. J. Immunol. 169: 2337-2345 [Abstract] [Full Text]  
• Legge, K. L., Gregg, R. K., Maldonado-Lopez, R., Li, L., Caprio, J. C., Moser, M., Zaghouani, H. (2002). On the Role of Dendritic Cells in Peripheral T Cell Tolerance and Modulation of Autoimmunity. JEM 196: 217-227 [Abstract] [Full Text]  
• Pack, C. D., Cestra, A. E., Min, B., Legge, K. L., Li, L., Caprio-Young, J. C., Bell, J. J., Gregg, R. K., Zaghouani, H. (2001). Neonatal Exposure to Antigen Primes the Immune System to Develop Responses in Various Lymphoid Organs and Promotes Bystander Regulation of Diverse T Cell Specificities. J. Immunol. 167: 4187-4195 [Abstract] [Full Text]  
• Li, L., Legge, K. L., Min, B., Bell, J. J., Gregg, R., Caprio, J., Zaghouani, H. (2001). Neonatal Immunity Develops in a Transgenic TCR Transfer Model and Reveals a Requirement for Elevated Cell Input to Achieve Organ-Specific Responses. J. Immunol. 167: 2585-2594 [Abstract] [Full Text]  
• Min, B., Legge, K. L., Bell, J. J., Gregg, R. K., Li, L., Caprio, J. C., Zaghouani, H. (2001). Neonatal Exposure to Antigen Induces a Defective CD40 Ligand Expression that Undermines Both IL-12 Production by APC and IL-2 Receptor Up-Regulation on Splenic T Cells and Perpetuates IFN-{{gamma}}-Dependent T Cell Anergy. J. Immunol. 166: 5594-5603 [Abstract] [Full Text]  
• Legge, K. L., Min, B., Bell, J. J., Caprio, J. C., Li, L., Gregg, R. K., Zaghouani, H. (2000). Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis. JEM 191: 2039-2052 [Abstract] [Full Text]  
• Anderson, A. C., Nicholson, L. B., Legge, K. L., Turchin, V., Zaghouani, H., Kuchroo, V. K. (2000). High Frequency of Autoreactive Myelin Proteolipid Protein-specific T Cells in the Periphery of Naive Mice: Mechanisms of Selection of the Self-reactive Repertoire. JEM 191: 761-770 [Abstract] [Full Text]  
• Legge, K. L., Min, B., Pack, C., Caprio, J., Zaghouani, H. (1999). Differential Presentation of an Altered Peptide Within Fetal Central and Peripheral Organs Supports an Avidity Model for Thymic T Cell Development and Implies a Peripheral Readjustment for Activation. J. Immunol. 162: 5738-5746 [Abstract] [Full Text]  
• Min, B., Legge, K. L., Pack, C., Zaghouani, H. (1998). Neonatal Exposure to a Self-Peptide-Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon gamma -mediated Splenic Anergy. JEM 188: 2007-2017 [Abstract] [Full Text]  
• Legge, K. L., Min, B., Cestra, A. E., Pack, C. D., Zaghouani, H. (1998). TCR Agonist and Antagonist Exert In Vivo Cross-Regulation When Presented on Igs. J. Immunol. 161: 106-111 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS